Fundraising Fox
Amazentis
Lausanne, CH · 2 known investors
Find your way into Amazentis
Sign up to find every way you can get introduced to Amazentis
- Your email: who you already know at Amazentis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Amazentis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy. It brings the molecule to consumers through its Timeline brand of supplements and skincare, and partners with companies including Nestlé Health Science and L'Oréal.
Investors · 2
In the news
Frequently asked questions
- What does Amazentis do?
- Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy. It brings the molecule to consumers through its Timeline brand of supplements and skincare, and partners with companies including Nestlé Health Science and L'Oréal.
- Who are Amazentis's investors?
- Amazentis's investors include Bold Capital Partners, +ND Capital.
- Where is Amazentis headquartered?
- Amazentis is headquartered in Lausanne, CH.